Companies: 10,739     total market cap: โ‚ฌ115.718 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Novo Nordisk
NVO
#105
Rank
โ‚ฌ140.55 B
Marketcap
๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Country
31,42ย โ‚ฌ
Share price
-1.52%
Change (1 day)
-53.20%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2025 (TTM): 3,09ย โ‚ฌ

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is 3,07ย โ‚ฌ. an increase over its 2024 EPS that were of 2,83ย โ‚ฌ.

EPS history for Novo Nordisk from 2016 to 2025

Annual EPS

Year EPS Change
20253,07ย โ‚ฌ8.34%
20242,83ย โ‚ฌ
20160,96ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
1,18ย โ‚ฌ-61.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
19,91ย โ‚ฌ 548.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,79ย โ‚ฌ-41.84%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
2,99ย โ‚ฌ-2.56%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com